Vise Technologies’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.29M | Buy |
+5,895
| New | +$2.29M | 0.09% | 225 |
|
|
2024
Q4 | $1.09M | Buy |
2,947
+830
| +39% | +$306K | 0.09% | 231 |
|
|
2024
Q3 | $1.1M | Buy |
2,117
+484
| +30% | +$252K | 0.14% | 146 |
|
|
2024
Q2 | $885K | Buy |
1,633
+127
| +8% | +$68.8K | 0.16% | 136 |
|
|
2024
Q1 | $781K | Sell |
1,506
-252
| -14% | -$131K | 0.15% | 140 |
|
|
2023
Q4 | $829K | Buy |
1,758
+7
| +0.4% | +$3.3K | 0.18% | 127 |
|
|
2023
Q3 | $762K | Buy |
1,751
+186
| +12% | +$81K | 0.19% | 121 |
|
|
2023
Q2 | $695K | Buy |
1,565
+174
| +13% | +$77.3K | 0.17% | 134 |
|
|
2023
Q1 | $640K | Buy |
1,391
+381
| +38% | +$175K | 0.17% | 138 |
|
|
2022
Q4 | $518K | Buy |
1,010
+25
| +3% | +$12.8K | 0.16% | 143 |
|
|
2022
Q3 | $447K | Buy |
985
+354
| +56% | +$161K | 0.17% | 143 |
|
|
2022
Q2 | $305K | Buy |
631
+87
| +16% | +$42.1K | 0.12% | 195 |
|
|
2022
Q1 | $267K | Buy |
+544
| New | +$267K | 0.1% | 188 |
|